Shares of Questcor (NASDAQ: QCOR) closed down 7% today, after Blue Cross Blue Shield Michigan came out against Acthar Gel in all indications except for infantile spasm. In this video, Motley Fool health-care analyst David Williamson dives into today's news, and explains what it means for investors going forward.
Blue Cross Blue Shield Michigan stirs the pot.
David Williamson has no positions in the stocks mentioned above. Follow him on Twitter @MotleyDavid.
The Motley Fool has no positions in the stocks mentioned above. Motley Fool newsletter services recommend UnitedHealth Group. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.